Abstract PS5-03-01: Phase I Study of Stereotactic Radiation and Sacituzumab Govitecan with Zimberelimab in the Management of Metastatic Triple Negative Breast Cancer with Brain Metastases
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps5-03-01